Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Hawkins

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Scientific Reports|November 19, 2025
Proof of concept for the usability of the IRRAMICE for proton preclinical radiobiological research by a traceable dosimetry evaluationReem Ahmad, Richard Coos, Ileana Silvestre Patallo, et al.
Oncotarget|February 11, 2016
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trialKhurum Khan, David Cunningham, Clare Peckitt, et al.
Journal of Immunotherapy and Precision Oncology|December 8, 2025
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV AdministrationLee S Rosen, Christian Ottensmeier, Maria Hawkins, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
The American Journal of Clinical Nutrition|July 7, 2017
Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapyLinda Wedlake, Clare Shaw, Helen McNair, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, et al.
Cancers|February 13, 2025
The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical OncologySean Ewings, Nadia Peppa, Daniel Griffiths, et al.
BMC Cancer|April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
BMJ Open|November 10, 2025
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, Alexandra Gilbert, Duncan Gilbert, et al.
Practical Radiation Oncology|November 27, 2024
Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused UpdateJennifer Y Wo, Jonathan B Ashman, Nishin A Bhadkamkar, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Scientific Reports|November 19, 2025
Proof of concept for the usability of the IRRAMICE for proton preclinical radiobiological research by a traceable dosimetry evaluationReem Ahmad, Richard Coos, Ileana Silvestre Patallo, et al.
Oncotarget|February 11, 2016
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trialKhurum Khan, David Cunningham, Clare Peckitt, et al.
Journal of Immunotherapy and Precision Oncology|December 8, 2025
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV AdministrationLee S Rosen, Christian Ottensmeier, Maria Hawkins, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
The American Journal of Clinical Nutrition|July 7, 2017
Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapyLinda Wedlake, Clare Shaw, Helen McNair, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, et al.
Cancers|February 13, 2025
The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical OncologySean Ewings, Nadia Peppa, Daniel Griffiths, et al.
BMC Cancer|April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
BMJ Open|November 10, 2025
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, Alexandra Gilbert, Duncan Gilbert, et al.
Practical Radiation Oncology|November 27, 2024
Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused UpdateJennifer Y Wo, Jonathan B Ashman, Nishin A Bhadkamkar, et al.
Pageof 4